¼¼°èÀÇ ´ÙÀ̾ó¶óÀÌÀú ½ÃÀå º¸°í¼­(2025³â)
Dialyzers Global Market Report 2025
»óǰÄÚµå : 1648704
¸®¼­Ä¡»ç : The Business Research Company
¹ßÇàÀÏ : On Demand Report
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 200 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,490 £Ü 6,371,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,490 £Ü 9,209,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,490 £Ü 12,048,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼¼°èÀÇ ´ÙÀ̾ó¶óÀÌÀú ½ÃÀå ±Ô¸ð´Â ÇâÈÄ ¼ö³â°£ °­·ÂÇÑ ¼ºÀåÀÌ ¿¹»óµË´Ï´Ù. 2029³â¿¡´Â CAGR 7.3%, ½ÃÀå ±Ô¸ð´Â 31¾ï 2,000¸¸ ´Þ·¯·Î ¼ºÀåÀÌ ¿¹»óµË´Ï´Ù. ¿¹Ãø±â°£ÀÇ ¼ºÀåÀº ¸¸¼º½ÅÀ庴ÀÇ À¯º´·ü Áõ°¡, °¡Ã³ºÐ¼Òµæ Áõ°¡, ÇコÄɾî ÁöÃâ Áõ°¡, ÀçÅÃÅõ¼®Ä¡·á ¼ö¿ä Áõ°¡ µî¿¡ ±âÀÎÇϰí ÀÖ½À´Ï´Ù. ¿¹Ãø ±â°£ÀÇ ÁÖ¿ä µ¿ÇâÀ¸·Î´Â ¿þ¾î·¯ºí Åõ¼® Àåºñ, ÀΰøÁö´É(AI) ÅëÇÕ, ¿ø°Ý ¸ð´ÏÅ͸µ, °¡Ä¡ ±â¹Ý ÄÉ¾î ¸ðµ¨, ¹ÙÀÌ¿À¿£Áö´Ï¾î¸µ ´ÙÀ̾ó¶óÀÌÀú µîÀÌ ÀÖ½À´Ï´Ù.

¸»±â ½ÅºÎÀüÀÇ ÀÌȯÀ² »ó½ÂÀº °¡±î¿î ¹Ì·¡ÀÇ ´ÙÀ̾ó¶óÀÌÀú ½ÃÀåÀÇ ¼ºÀåÀ» °ßÀÎÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¸»±â ½ÅºÎÀü(ESRF)Àº ¸»±â ½ÅÀå Áúȯ(ESRD)À̶ó°íµµ ºÒ¸®¸ç, ½ÅÀåÀÌ ´õ ÀÌ»ó µ¶¸³ÀûÀ¸·Î ±â´ÉÇÒ ¼ö ¾ø´Â ¼öÁرîÁö ½ÅÀå ±â´ÉÀÌ °¨¼ÒµÈ ¸¸¼º ½ÅÀå ÁúȯÀÇ µ¹ÀÌų ¼ö ¾ø´Â ÃÖÁ¾ ´Ü°è¸¦ ³ªÅ¸³À´Ï´Ù. Åõ¼®Àº Ç÷¾×¿¡¼­ ³ëÆó¹°°ú ¿©ºÐÀÇ ¼öºÐÀ» Á¦°ÅÇÏ°í ¿©°úµÈ Ç÷¾×À» ´Ù½Ã ü³»·Î µÇµ¹¸®±â À§ÇØ ¼öÇàµË´Ï´Ù. ¿¹¸¦ µé¾î 2024³â 6¿ù ¿¹¹æ °¡´ÉÇÑ ½ÅÀ庴 ´ëÃ¥¿¡ ÁßÁ¡À» µÐ Àεµ¿¡ º»ºÎ¸¦ µÐ ´Üü National Kidney FoundationÀº ¹Ì±¹¿¡¼­´Â 2023³â±îÁö ¾à 3,550¸¸¸íÀÌ ¸¸¼º ½ÅÀ庴À¸·Î Áø´ÜµÇ¾î ¼ºÀÎÀÇ 33%, Áï 3¸í Áß 1¸í ÀÌ»óÀÌ ¸¸¼º ½ÅÀ庴À̶ó°í º¸°íÇß½À´Ï´Ù. ¶ÇÇÑ ÈæÀÎ/¾ÆÇÁ¸®Ä«°è ¹Ì±¹ÀÎÀº ¹Ì±¹ Àα¸ÀÇ 13%¸¦ Â÷ÁöÇÏÁö¸¸ ½ÅºÎÀü ȯÀÚÀÇ 30%¸¦ Â÷ÁöÇÕ´Ï´Ù. ½ÅÀ庴 ȯÀÚ´Â Àüü ¸ÞµðÄɾî ÁöÃâÀÇ ¾à 4ºÐÀÇ 1À» Â÷ÁöÇϰí ÀÖÀ¸¸ç, ÀÌ ±Ý¾×Àº 1,567¾ï ´Þ·¯¿¡ À̸£·¯ ´õ¿í Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ¿Í °°ÀÌ ¸»±â ½ÅºÎÀüÀÇ ÀÌȯÀ² »ó½ÂÀÌ ´ÙÀ̾ó¶óÀÌÀú ½ÃÀåÀÇ ¼ºÀåÀ» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù.

´ç´¢º´°ú ½ÉÇ÷°ü ÁúȯÀÇ ÀÌȯÀ² »ó½ÂÀº ´ÙÀ̾ó¶óÀÌÀú ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÒ Àü¸ÁÀÔ´Ï´Ù. ´ç´¢º´°ú ½ÉÇ÷°ü ÁúȯÀº ½É°¢ÇÑ °Ç°­ À§ÇèÀ» ÃÊ·¡Çϰí, Ç÷´çÀÇ »ó½ÂÀº ½ÉÀå °ü·Ã ÁúȯÀÇ ÀáÀç·ÂÀ» Áõ°¡½Ãŵ´Ï´Ù. ´ç´¢º´°ú ½ÉÇ÷°ü ÁúȯÀ» ¾Î°í Àִ ȯÀÚ´Â ´ÙÀ̾ó¶óÀÌÀú¸¦ ÀÌ¿ëÇÏ¿© ³ëÆó¹°°ú ¿©ºÐÀÇ ¼öºÐÀ» Ç÷·ù·ÎºÎÅÍ Á¦°ÅÇϰí, ÀáÀçÀûÀÎ ½Å±â´ÉÀå¾Ö¿Í ¿©°úÀå¾Ö¿¡ ´ëóÇÔÀ¸·Î½á ÇÕº´ÁõÀ» °ü¸®Çϰí, ÀüüÀûÀÎ °Ç°­À» ÁõÁøÇϰí ÀÖ½À´Ï´Ù. ¼¼°èº¸°Ç±â±¸(WHO)¿¡ µû¸£¸é ¸¸¼ºÁúȯÀº ¼¼°è »ç¸ÁÀÇ 74%¸¦ Â÷ÁöÇÏ¸ç ¿¬°£ 4,100¸¸ ¸íÀÌ »ç¸ÁÇϰí ÀÖ½À´Ï´Ù. ±× ³»¿ªÀº ½ÉÇ÷°ü Áúȯ¿¡ ÀÇÇÑ »ç¸ÁÀÌ 1,790¸¸¸í, ¾Ï¿¡ ÀÇÇÑ »ç¸ÁÀÌ 930¸¸¸í, ¸¸¼º È£Èí±â Áúȯ¿¡ ÀÇÇÑ »ç¸ÁÀÌ 410¸¸¸í, ´ç´¢º´¿¡ ÀÇÇÑ »ç¸ÁÀÌ 200¸¸¸íÀÔ´Ï´Ù. ´ç´¢º´°ú ½ÉÇ÷°ü Áúȯ Áõ°¡À²ÀÌ ´ÙÀ̾ó¶óÀÌÀú ½ÃÀå È®´ëÀÇ ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå Æ¯Â¡

Á¦3Àå ½ÃÀå µ¿Çâ°ú Àü·«

Á¦4Àå ½ÃÀå - ±Ý¸®, ÀÎÇ÷¹À̼Ç, ÁöÁ¤ÇÐ, Äڷγª, ȸº¹ÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» Æ÷ÇÔÇÑ °Å½Ã °æÁ¦ ½Ã³ª¸®¿À

Á¦5Àå ¼¼°èÀÇ ¼ºÀå ºÐ¼®°ú Àü·« ºÐ¼® ÇÁ·¹ÀÓ¿öÅ©

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­

Á¦7Àå Áö¿ªº°¡¤±¹°¡º° ºÐ¼®

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦9Àå Áß±¹ ½ÃÀå

Á¦10Àå Àεµ ½ÃÀå

Á¦11Àå ÀϺ» ½ÃÀå

Á¦12Àå È£ÁÖ ½ÃÀå

Á¦13Àå Àεµ³×½Ã¾Æ ½ÃÀå

Á¦14Àå Çѱ¹ ½ÃÀå

Á¦15Àå ¼­À¯·´ ½ÃÀå

Á¦16Àå ¿µ±¹ ½ÃÀå

Á¦17Àå µ¶ÀÏ ½ÃÀå

Á¦18Àå ÇÁ¶û½º ½ÃÀå

Á¦19Àå ÀÌÅ»¸®¾Æ ½ÃÀå

Á¦20Àå ½ºÆäÀÎ ½ÃÀå

Á¦21Àå µ¿À¯·´ ½ÃÀå

Á¦22Àå ·¯½Ã¾Æ ½ÃÀå

Á¦23Àå ºÏ¹Ì ½ÃÀå

Á¦24Àå ¹Ì±¹ ½ÃÀå

Á¦25Àå ij³ª´Ù ½ÃÀå

Á¦26Àå ³²¹Ì ½ÃÀå

Á¦27Àå ºê¶óÁú ½ÃÀå

Á¦28Àå Áßµ¿ ½ÃÀå

Á¦29Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦30Àå °æÀï ±¸µµ¿Í ±â¾÷ ÇÁ·ÎÆÄÀÏ

Á¦31Àå ±âŸ ÁÖ¿ä ±â¾÷ ¹× Çõ½Å ±â¾÷

Á¦32Àå ¼¼°è ½ÃÀå °æÀï º¥Ä¡¸¶Å·°ú ´ë½Ãº¸µå

Á¦33Àå ÁÖ¿ä ÀμöÇÕº´(M&A)

Á¦34Àå ½ÃÀåÀÇ ÃÖ±Ù µ¿Çâ

Á¦35Àå ½ÃÀåÀÇ ÀáÀç·ÂÀÌ ³ôÀº ±¹°¡, ºÎ¹®, Àü·«

Á¦36Àå ºÎ·Ï

JHS
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

A dialyzer is a medical device utilized for filtering waste chemicals and eliminating excess fluid from an individual's blood in cases where the kidneys are not functioning properly. It acts as a substitute for the kidneys by employing semipermeable membranes to separate compounds in solution through uneven diffusion. This process effectively filters pollutants from the bloodstream of patients with kidney malfunction.

The primary types of dialyzers are high-flux dialyzers and low-flux dialyzers. High-flux dialyzers feature larger holes, allowing them to remove larger molecules such as beta-2 microglobulin. These dialyzers can be categorized based on their usage as disposable or reusable and can be employed in various settings, including in-center dialysis, home dialysis, hospital dialysis, independent dialysis, peritoneal dialysis, and home hemodialysis.

The dialyzers market research report is one of a series of new reports from The Business Research Company that provides dialyzers market statistics, including dialyzers industry global market size, regional shares, competitors with a dialyzers market share, detailed dialyzers market segments, market trends and opportunities, and any further data you may need to thrive in the dialyzers industry. This dialyzers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The dialyzers market size has grown strongly in recent years. It will grow from $2.24 billion in 2024 to $2.36 billion in 2025 at a compound annual growth rate (CAGR) of 5.4%. The growth in the historic period can be attributed to aging population, improved healthcare infrastructure, rise in research and development, increase in number of dialysis centers.

The dialyzers market size is expected to see strong growth in the next few years. It will grow to $3.12 billion in 2029 at a compound annual growth rate (CAGR) of 7.3%. The growth in the forecast period can be attributed to increasing prevalence of chronic kidney diseases, rising disposable income, rising healthcare expenditure, growing demand for home dialysis treatment. Major trends in the forecast period include wearable dialysis devices, artificial intelligence (ai) integration, remote monitoring, value-based care models, bioengineered dialyzers.

The rising incidence of end-stage renal disease is anticipated to drive the growth of the dialyzer market in the near future. End-stage renal failure (ESRF), also known as end-stage renal disease (ESRD), represents the final, irreversible stage of chronic kidney disease, during which kidney function has declined to a level that the kidneys can no longer function independently. A dialyzer is utilized in the dialysis process to remove waste and excess fluid from the bloodstream, subsequently reinfusing the filtered blood back into the body of patients with end-stage renal disease. For example, in June 2024, the National Kidney Foundation, an organization based in India focused on combating preventable kidney disease, reported that nearly 35.5 million people in the US were diagnosed with chronic kidney disease by 2023, accounting for 33 percent of adults, or more than one in three. Additionally, while Black/African American individuals make up 13% of the U.S. population, they represent 30% of all kidney failure cases. Kidney patients receive about one-fourth of all Medicare expenditures, amounting to $156.7 billion and increasing. Thus, the rising incidence of end-stage renal disease is fueling the growth of the dialyzer market.

The rising rates of diabetes and cardiovascular disease are poised to propel the dialyzer market's growth. Diabetes and cardiovascular disease pose significant health risks, with elevated blood sugar levels contributing to an increased likelihood of heart-related conditions. Patients afflicted with diabetes and cardiovascular disease utilize dialyzers to eliminate waste products and excess fluids from their bloodstream, managing complications and enhancing overall health by addressing potential kidney dysfunction and impaired filtration. According to the World Health Organization, chronic diseases account for 74% of global fatalities, with 41 million deaths annually, encompassing 17.9 million deaths from cardiovascular diseases, 9.3 million from cancer, 4.1 million from chronic respiratory diseases, and 2.0 million from diabetes. The mounting rates of diabetes and cardiovascular disease underscore the driving force behind the dialyzer market's expansion.

Major companies in the dialyzer market are concentrating on developing innovative products, such as hemocompatible dialyzers, to ensure reliable patient care. A hemocompatible dialyzer is specifically designed to reduce the activation of the blood's clotting system and the inflammatory response, thereby lowering the risk of complications during dialysis, including blood clots, bleeding, and infections. For example, in February 2024, Fresenius Medical Care AG & Co. KGaA, a German manufacturer of dialyzers, introduced the 5008X Hemodialysis System. This system and its accompanying FX CorAL dialyzer demonstrate the company's global leadership in innovation within medical device and membrane engineering technologies. The 5008X Hemodialysis System integrates advanced device engineering with membrane technologies to facilitate high-volume hemodiafiltration.

Major companies in the dialyzer market are pursuing a strategic partnership approach to enhance the quality of life and overall patient care experience for individuals with end-stage renal disease (ESRD). Strategic partnerships involve companies utilizing each other's strengths and resources to achieve mutual benefits and success. For example, in September 2023, Alio Inc., a US-based medtech company, collaborated with Lifeline Vascular Care, a US-based medical firm, to introduce a new feature for its SmartPatch remote monitoring platform. This feature alerts clinicians to unusual acoustic data from a patient's vascular access site. The goal of this partnership is to improve patient management, particularly for those with end-stage kidney disease (ESKD), by enabling proactive monitoring without the necessity for frequent in-person visits.

In another strategic move, B. Braun SE, a prominent Germany-based manufacturer of dialyzers, executed an acquisition in March 2022 by acquiring Intermedt Medizin & Technik GmbH for an undisclosed amount. This strategic acquisition positions B. Braun to fortify and expand its product portfolio by gaining access to the comprehensive range of dialysis products and services offered by Intermedt. As a Germany-based manufacturer specializing in dialyzers and dialysis concentrates, Intermedt Medizin & Technik GmbH becomes an integral component of B. Braun's strategic growth and development in the dialyzer market. Through such strategic initiatives, major companies in the dialyzer market are not only enhancing their product offerings but also leveraging collaborations and acquisitions to shape the future landscape of patient care in the realm of end-stage renal disease.

Major companies operating in the dialyzers market include Medtronic PLC, Asahi Kasei Medical Co Ltd., Toray Medical Co Ltd., Baxter International Inc., B. Braun Melsungen AG, Terumo Corporation, Nipro Corporation, Nikkiso Co Ltd., Weigao group, Fresenius Medical Care AG & Co KGaA, Allmed Medical Products Co Ltd., NxStage Medical Inc., Jiangxi Sanxin Medical Technology Co Ltd., Rockwell Medical Inc., Xenios AG., Kawasumi Laboratories Incorporated., Dialife SA, Anhui Jinye Industrial Co Ltd., Haidylena, and Farmasol S.A

North America was the largest region in the dialyzers market in 2024. The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the Dialyzers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The dialyzer market consists of revenues earned by entities by providing services such as removal of excess fluid, filtering blood from waste products. The market value includes the value of related goods sold by the service provider or included within the service offering. The dialyzer market also consists of sales of tube-type dialyzers, flat-type dialyzers, and hollow fiber-type dialyzers. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Dialyzers Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on dialyzers market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for dialyzers ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The dialyzers market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Dialyzers Market Characteristics

3. Dialyzers Market Trends And Strategies

4. Dialyzers Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Dialyzers Growth Analysis And Strategic Analysis Framework

6. Dialyzers Market Segmentation

7. Dialyzers Market Regional And Country Analysis

8. Asia-Pacific Dialyzers Market

9. China Dialyzers Market

10. India Dialyzers Market

11. Japan Dialyzers Market

12. Australia Dialyzers Market

13. Indonesia Dialyzers Market

14. South Korea Dialyzers Market

15. Western Europe Dialyzers Market

16. UK Dialyzers Market

17. Germany Dialyzers Market

18. France Dialyzers Market

19. Italy Dialyzers Market

20. Spain Dialyzers Market

21. Eastern Europe Dialyzers Market

22. Russia Dialyzers Market

23. North America Dialyzers Market

24. USA Dialyzers Market

25. Canada Dialyzers Market

26. South America Dialyzers Market

27. Brazil Dialyzers Market

28. Middle East Dialyzers Market

29. Africa Dialyzers Market

30. Dialyzers Market Competitive Landscape And Company Profiles

31. Dialyzers Market Other Major And Innovative Companies

32. Global Dialyzers Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Dialyzers Market

34. Recent Developments In The Dialyzers Market

35. Dialyzers Market High Potential Countries, Segments and Strategies

36. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â